Results
20,958 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Hafer EvanDirector, Founder, 10% Owner |  BRCCBRC Inc.Open-market sale · 10b5-1 plan | SELL | $163K 15.3K sh | Oct 15, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Open-market sale · 10b5-1 plan | SELL | $163K 15.3K sh | Oct 15, 2026 |
| 16 | Bicket JohnDirector, SEE REMARKS, 10% Owner |  IOTSamsara Inc.Open-market sale · 10b5-1 plan | SELL | $246K 5,995 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 15 | King David R.See Remarks |  FLYWFlywire CorpOpen-market sale · 10b5-1 plan | SELL | $676K 36.9K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 15 | Faust MeganCFO |  AMKRAMKOR TECHNOLOGY, INC.Open-market sale · 10b5-1 plan | SELL | $47K 1,000 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 14 | Eddy Robert W.Director, President & CEO |  BJBJ's Wholesale Club Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $1.63M 15.8K sh | Oct 15, 2026 traded Oct 14, 2026 |
| 14 |  Silverman JoshDirector, Executive Chair of the Board |  ETSYETSY INCOpen-market sale · 10b5-1 plan | SELL | $56K 714 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 14 | Eddy Robert W.Director, President & CEO | BJBJ's Wholesale Club Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $1.24M 12.4K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 14 | Eddy Robert W.Director, President & CEO | BJBJ's Wholesale Club Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $3.81M 37.5K sh | Oct 15, 2026 traded Oct 14, 2026 |
| 13 | Thakar Sumedh SDirector, CEO & PRESIDENT |  QLYSQUALYS, INC.Open-market sale · 10b5-1 plan | SELL | $76K 400 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 13 | Thakar Sumedh SDirector, CEO & PRESIDENT | QLYSQUALYS, INC. Open-market sale · 10b5-1 plan | SELL | $75K 400 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 13 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Open-market sale · 10b5-1 plan | SELL | $2,100 200 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 13 | Thakar Sumedh SDirector, CEO & PRESIDENT | QLYSQUALYS, INC. Open-market sale · 10b5-1 plan | SELL | $78K 400 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 13 | Thakar Sumedh SDirector, CEO & PRESIDENT | QLYSQUALYS, INC. Open-market sale · 10b5-1 plan | SELL | $96K 500 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 11 | Murphy Andrew JCo-Chief Scientific Officer |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $296K 380 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 11 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $361K 463 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 11 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $354K 454 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 11 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $292K 376 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 10 | Eddy Robert W.Director, President & CEO | BJBJ's Wholesale Club Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $1.81M 18.0K sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $404K 1,611 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $414K 1,644 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $426K 1,676 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $371K 1,468 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $258K 1,014 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $394K 1,484 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $386K 1,544 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $522K 1,997 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $348K 1,320 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $862K 3,283 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $81K 105 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $56K 74 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $214K 279 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $167K 219 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $94K 121 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $218K 283 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $147K 192 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $98K 127 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $163K 211 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $207K 271 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $51K 66 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $173K 224 sh | Oct 15, 2026 traded Oct 14, 2026 |